Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of MEDI-575 in Adult Subjects With Recurrent Glioblastoma Multiforme

NCT01268566 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT01268566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01268566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of MEDI-575 in Adult Subjects With Recurrent Glioblastoma Multiforme
Lead sponsor
MedImmune LLC
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2011
Completion date
November 30, 2012
Enrollment
62 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme